Important Announcement for Geron Corporation Investors
Levi & Korsinsky, LLP is reaching out to all investors in Geron Corporation, also known simply as Geron. The firm is bringing to attention a class action securities lawsuit that could impact you. This action is crucial for those who may have experienced financial losses due to alleged securities fraud affecting Geron’s stock performance.
Understanding the Class Action Lawsuit
This class action lawsuit aims to recover losses for investors adversely affected by questionable securities practices during a defined period. Specifically, the lawsuit covers the time frame from February 28, 2024, to February 25, 2025. This is your chance to be part of a collective effort to seek justice and potentially recover losses you may have incurred during this time.
Details of the Allegations
At the heart of the lawsuit are claims regarding misleading information provided by Geron’s executives. During the relevant period, the executives allegedly made optimistic statements about the expected launch of Rytelo (imetelstat) and its market potential. Investors were led to believe in the drug’s substantial promise and unmet demand, while risk factors were downplayed. Following an announcement revealing underwhelming growth for Rytelo, the stock saw a drastic decline, illustrating the severe financial implications of the concerns raised in the lawsuit.
Potential Timeline for Investors
If you faced financial losses associated with Geron’s stock, it is crucial to act fast. The deadline for appointing a lead plaintiff is set for May 12, 2025. However, you do not need to be a lead plaintiff to benefit from any recovery resulting from this class action suit. Your participation could still provide you with the chance to recover some funds.
No Cost Involved for Class Members
If you are classified as a member of this class, you might be eligible for compensation without any upfront costs or obligations. It’s vital to understand that participating doesn’t require any payment from you, creating a risk-free opportunity to seek justice.
Why Choose Levi & Korsinsky?
With over two decades of experience, Levi & Korsinsky has established a considerable reputation for securing victories for investors in complex litigation. The firm has accumulated hundreds of millions of dollars in recoveries for aggrieved shareholders. Their team, comprised of over 70 dedicated professionals, is committed to supporting clients through challenging times. Recognized consistently in top securities litigation rankings, their expertise in this field cannot be overstated.
Contact Information for Further Details
If you would like to learn more or believe you may be eligible for participation in this class action, please reach out to Levi & Korsinsky. Get in touch with Joseph E. Levi, Esq., or Ed Korsinsky, Esq., who will guide you through the necessary steps to connect. Their office is located at 33 Whitehall Street, 17th Floor, New York, NY 10004. The firm can also be reached by telephone at (212) 363-7500.
Frequently Asked Questions
What is the class action lawsuit about?
The class action lawsuit addresses potential securities fraud related to Geron Corporation's stock performance during a specified timeframe.
Who can participate in the lawsuit?
Anyone who suffered financial losses due to Geron's stock during the defined timeline may be eligible to join the lawsuit.
What is the deadline for joining the class action?
The deadline to apply to be the lead plaintiff is May 12, 2025. However, you do not need to be a lead plaintiff to participate in the recovery.
Is there a cost to participate?
No, there are no out-of-pocket costs for class members to join this lawsuit, making it a straightforward opportunity for participation.
How can I contact Levi & Korsinsky for more details?
Investors can contact Levi & Korsinsky by calling their office at (212) 363-7500 for more information and assistance.
